Henry Ford Health System
2 clinical trials · 2 recruiting · OTHER
Trials by Henry Ford Health System
RECRUITINGPhase 1NCT06065371
Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on...
This is a Phase I study to evaluate the safety and tolerability of sacituzumab govitecan in combination with capecitabine for advanced gastrointestinal cancers after progression...
Sponsor: Henry Ford Health SystemEnrolling: 201 location
Gastrointestinal Cancer
RECRUITINGNCT06269510
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
The purpose of this trial is to see if providing patients with alcohol-related liver disease with tailored alcohol use treatment options will increase engagement with treatment...
Sponsor: Henry Ford Health SystemEnrolling: 2681 location
Alcohol-related Liver DiseaseLiver Diseases